{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:55:47Z","timestamp":1778867747925,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T00:00:00Z","timestamp":1394496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T00:00:00Z","timestamp":1394496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/pcan.2014.7","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T11:26:38Z","timestamp":1394537198000},"page":"187-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening For Prostate Cancer (ERSPC)"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1548-7248","authenticated-orcid":false,"given":"M","family":"Luj\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"P\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J C","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Granados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Nevado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G M","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BFpcan20147_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"BFpcan20147_CR2","unstructured":"SEER Cancer Statistics Review 1975\u20132010. Table 23.10\u2013Cancer of the Prostate (Invasive). Risk of Being Diagnosed With Cancer in 10, 20 and 30 Years, Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age, and Lifetime Risk of Dying from Cancer Given Alive at Current Age Males, 2008\u20132010 By Race\/Ethnicity. National Cancer Institute: Bethesda, MD, USA http:\/\/seer.cancer.gov\/csr\/1975_2010\/browse_csr.php?section=23&page=sect_23_table.10.html. Last updated 1 June 2013. Last accessed 14 September 2013."},{"key":"BFpcan20147_CR3","unstructured":"Eurostat. European Comission http:\/\/epp.eurostat.ec.europa.eu\/portal\/page\/portal\/statistics\/search_database. (accessed 14 September 2013)."},{"key":"BFpcan20147_CR4","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","volume":"360","author":"GL Andriole","year":"2009","unstructured":"Andriole GL, Crawford ED, Grubb III RL, Buys SS, Chia D, Church TR et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360: 1310\u20131319.","journal-title":"N Engl J Med"},{"key":"BFpcan20147_CR5","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","volume":"360","author":"FH Schroder","year":"2009","unstructured":"Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320\u20131328.","journal-title":"N Engl J Med"},{"key":"BFpcan20147_CR6","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1113135","volume":"366","author":"FH Schroder","year":"2012","unstructured":"Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012; 366: 981\u2013990.","journal-title":"N Engl J Med"},{"key":"BFpcan20147_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.eururo.2013.08.005","volume":"65","author":"LP Bokhorst","year":"2013","unstructured":"Bokhorst LP, Bangma CH, van Leenders GJ, Lous JJ, Moss SM, Schroder FH et al. Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of screening for prostate cancer. Eur Urol 2013; 65: 329\u2013336.","journal-title":"Eur Urol"},{"key":"BFpcan20147_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S1470-2045(10)70146-7","volume":"11","author":"J Hugosson","year":"2010","unstructured":"Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P et al. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010; 11: 725\u2013732.","journal-title":"Lancet Oncol"},{"key":"BFpcan20147_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/jnci\/djr500","volume":"104","author":"GL Andriole","year":"2012","unstructured":"Andriole GL, Crawford ED, Grubb III RL, Buys SS, Chia D, Church TR et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012; 104: 125\u2013132.","journal-title":"J Natl Cancer Inst"},{"key":"BFpcan20147_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1740774510374091","volume":"7","author":"PF Pinsky","year":"2010","unstructured":"Pinsky PF, Blacka A, Kramer BS, Miller A, Prorok PC, Berg C . Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Clin Trials 2010; 7: 303\u2013311.","journal-title":"Clin Trials"},{"key":"BFpcan20147_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-157-2-201207170-00463","volume":"157","author":"WJ Catalona","year":"2012","unstructured":"Catalona WJ, D'Amico AV, Fitzgibbons WF, Kosoko-Lasaki O, Leslie SW, Lynch HT et al. What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation. Ann Intern Med 2012; 157: 137\u2013138.","journal-title":"Ann Intern Med"},{"key":"BFpcan20147_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/jnci\/djp001","volume":"101","author":"G Draisma","year":"2009","unstructured":"Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009; 101: 374\u2013383.","journal-title":"J Natl Cancer Inst"},{"key":"BFpcan20147_CR13","doi-asserted-by":"crossref","unstructured":"Ilic D, Neuberger MM, Djulbegovic M, Dahm P . Screening for prostate cancer. Cochrane Database Syst Rev 2013, 1 CD004720.","DOI":"10.1002\/14651858.CD004720.pub3"},{"key":"BFpcan20147_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.7326\/0003-4819-155-11-201112060-00375","volume":"155","author":"R Chou","year":"2011","unstructured":"Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155: 762\u2013771.","journal-title":"Ann Intern Med"},{"key":"BFpcan20147_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","volume":"157","author":"VA Moyer","year":"2012","unstructured":"Moyer VA . Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157: 120\u2013134.","journal-title":"Ann Intern Med"},{"key":"BFpcan20147_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.eururo.2013.06.051","volume":"64","author":"A Heidenreich","year":"2013","unstructured":"Heidenreich A, Abrahamsson PA, Artibani W, Catto J, Montorsi F, Van PH et al. Early detection of prostate cancer: European association of urology recommendation. Eur Urol 2013; 64: 347\u2013354.","journal-title":"Eur Urol"},{"key":"BFpcan20147_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","volume":"190","author":"HB Carter","year":"2013","unstructured":"Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL et al. Early detection of prostate cancer: AUA Guideline. J Urol 2013; 190: 419\u2013426.","journal-title":"J Urol"},{"key":"BFpcan20147_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.acuro.2011.10.013","volume":"36","author":"M Lujan","year":"2012","unstructured":"Lujan M, Paez A, Berenguer A, Rodriguez JA . Mortality due to prostate cancer in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Results after a 15-year follow-up. Actas Urol Esp 2012; 36: 403\u2013409.","journal-title":"Actas Urol Esp"},{"key":"BFpcan20147_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ijc.10188","volume":"98","author":"HJ de Koning","year":"2002","unstructured":"de Koning HJ, Liem MK, Baan CA, Boer R, Schroder FH, Alexander FE . Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial. Int J Cancer 2002; 98: 268\u2013273.","journal-title":"Int J Cancer"},{"issue":"Suppl 2","key":"BFpcan20147_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1465-5101.2003.04393.x","volume":"92","author":"A Berenguer","year":"2003","unstructured":"Berenguer A, Lujan M, Paez A, Santonja C, Pascual T . The Spanish contribution to the European Randomized Study of Screening for Prostate Cancer. BJU Int 2003; 92 (Suppl 2): 33\u201338.","journal-title":"BJU Int"},{"issue":"Suppl 2","key":"BFpcan20147_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1465-5101.2003.04404.x","volume":"92","author":"A Paez","year":"2003","unstructured":"Paez A, Lujan M, Raaijmakers R, Berenguer A . Four-year prostate-specific antigen progression in the non-cancer population of the European Randomized Study of Screening for Prostate Cancer. BJU Int 2003; 92 (Suppl 2): 84\u201387.","journal-title":"BJU Int"},{"key":"BFpcan20147_CR22","first-page":"6756","volume":"20","author":"X Zhu","year":"2013","unstructured":"Zhu X, Kranse R, Bul M, Bangma CH, Schroder FH, Roobol MJ . Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method. Can J Urol 2013; 20: 6756\u20136760.","journal-title":"Can J Urol"},{"key":"BFpcan20147_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.eururo.2013.05.030","volume":"64","author":"MJ Roobol","year":"2013","unstructured":"Roobol MJ, Kranse R, Bangma CH, van Leenders AG, Blijenberg BG, van Schaik RH et al. Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer. Eur Urol 2013; 64: 530\u2013539.","journal-title":"Eur Urol"},{"key":"BFpcan20147_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jnci\/djt038","volume":"105","author":"TP Kilpelainen","year":"2013","unstructured":"Kilpelainen TP, Tammela TL, Malila N, Hakama M, Santti H, Maattanen L et al. Prostate cancer mortality in the Finnish randomized screening trial. J Natl Cancer Inst 2013; 105: 719\u2013725.","journal-title":"J Natl Cancer Inst"},{"key":"BFpcan20147_CR25","unstructured":"Instituto Nacional de Estad\u00edstica. Deaths according to cause of death. INE-Standardised Methodological Report. Instituto Nacional de Estadistica, Madrid, Spain. http:\/\/www.ine.es\/dynt3\/metadatos\/en\/RespuestaPrint.htm?oper=23. Last updated 1 January 2013. Last accessed 24 September 2013."},{"issue":"Suppl 3","key":"BFpcan20147_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1157\/13101089","volume":"20","author":"B Perez-Gomez","year":"2006","unstructured":"Perez-Gomez B, Aragones N, Pollan M, Suarez B, Lope V, Llacer A et al. Accuracy of cancer death certificates in Spain: a summary of available information. Gac Sanit 2006; 20 (Suppl 3): 42\u201351.","journal-title":"Gac Sanit"},{"issue":"Suppl 2","key":"BFpcan20147_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1465-5101.2003.04402.x","volume":"92","author":"HJ de Koning","year":"2003","unstructured":"de Koning HJ, Blom J, Merkelbach JW, Raaijmakers R, Verhaegen H, Van VP et al. Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int 2003; 92 (Suppl 2): 71\u201378.","journal-title":"BJU Int"},{"key":"BFpcan20147_CR28","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1016\/j.ejca.2010.09.026","volume":"46","author":"SJ Otto","year":"2010","unstructured":"Otto SJ, van Leeuwen PJ, Hoekstra JW, Merckelbach JW, Blom JH, Schroder FH et al. Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial? Eur J Cancer 2010; 46: 3061\u20133067.","journal-title":"Eur J Cancer"},{"key":"BFpcan20147_CR29","unstructured":"Instituto Nacional de Estad\u00edstica. Deaths according to cause of death. Year 2011. Instituto Nacional de Estadistica, Madrid, Spain. http:\/\/www.ine.es\/prensa\/np767.pdf. Last updated 27 February 2012. Last accessed 14 September 2013."},{"key":"BFpcan20147_CR30","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.eururo.2006.04.015","volume":"50","author":"M Lujan","year":"2006","unstructured":"Lujan M, Paez A, Pascual C, Angulo J, Miravalles E, Berenguer A . Extent of prostate-specific antigen contamination in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2006; 50: 1234\u20131240.","journal-title":"Eur Urol"},{"key":"BFpcan20147_CR31","unstructured":"Instituto Nacional de Estad\u00edstica (INE). Basic demographic indicators. Instituto Nacional de Estadistica, Madrid, Spain. http:\/\/www.ine.es\/inebmenu\/mnu_dinamicapob.htm. Last updated 18 June 2013. Last accessed 22 September 2013."},{"key":"BFpcan20147_CR32","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa1011967","volume":"364","author":"A Bill-Axelson","year":"2011","unstructured":"Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011; 364: 1708\u20131717.","journal-title":"N Engl J Med"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/pcan20147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan20147","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan20147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:38:28Z","timestamp":1648676308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pcan20147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,11]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["BFpcan20147"],"URL":"https:\/\/doi.org\/10.1038\/pcan.2014.7","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,11]]},"assertion":[{"value":"30 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}